MediciNova, Inc.
COMBINATION OF IBUDILAST AND INTERFERON-BETA AND METHODS OF USING SAME

Last updated:

Abstract:

This disclosure is directed to methods of alleviating the negative effects of, treating, or slowing the progression of progressive multiple sclerosis in human patients using ibudilast and interferon-beta.

Status:
Application
Type:

Utility

Filling date:

8 Oct 2019

Issue date:

9 Apr 2020